Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models

Cell
Waleed MinzelYinon Ben-Neriah

Abstract

CKIα ablation induces p53 activation, and CKIα degradation underlies the therapeutic effect of lenalidomide in a pre-leukemia syndrome. Here we describe the development of CKIα inhibitors, which co-target the transcriptional kinases CDK7 and CDK9, thereby augmenting CKIα-induced p53 activation and its anti-leukemic activity. Oncogene-driving super-enhancers (SEs) are highly sensitive to CDK7/9 inhibition. We identified multiple newly gained SEs in primary mouse acute myeloid leukemia (AML) cells and demonstrate that the inhibitors abolish many SEs and preferentially suppress the transcription elongation of SE-driven oncogenes. We show that blocking CKIα together with CDK7 and/or CDK9 synergistically stabilize p53, deprive leukemia cells of survival and proliferation-maintaining SE-driven oncogenes, and induce apoptosis. Leukemia progenitors are selectively eliminated by the inhibitors, explaining their therapeutic efficacy with preserved hematopoiesis and leukemia cure potential; they eradicate leukemia in MLL-AF9 and Tet2-/-;Flt3ITD AML mouse models and in several patient-derived AML xenograft models, supporting their potential efficacy in curing human leukemia.

Citations

Nov 8, 2018·The New England Journal of Medicine·Benjamin L Ebert, Jan Krönke
Jan 29, 2019·Journal of Molecular Cell Biology·Marcus J G W Ladds, Sonia Laín
May 17, 2019·Bioscience, Biotechnology, and Biochemistry·Thomas BöhmJoachim Bischof
Apr 25, 2020·Biomolecules·Jerson L SilvaVitor F Ferreira
May 10, 2020·Experimental & Molecular Medicine·Qunying JiaFaqing Tang
Feb 20, 2019·Current Treatment Options in Oncology·Chi-Che Hsieh, Che-Hung Shen
Jun 16, 2019·International Journal of Molecular Sciences·Simon J BaumgartBernard Haendler
Feb 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Koh Fujinaga
Mar 8, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Leonidas BenetatosGeorge Vartholomatos
Jun 24, 2020·Nature Chemical Biology·Pabitra K Parua, Robert P Fisher
Nov 5, 2019·Frontiers in Oncology·Alina-Andreea ZimtaIoana Berindan-Neagoe
Jul 18, 2019·Journal of Hematology & Oncology·Yunlu JiaJianbiao Zhou
Dec 12, 2020·The Biochemical Journal·Luke J Fulcher, Gopal P Sapkota
Jan 15, 2019·European Journal of Medicinal Chemistry·Weiyan ChengQuancheng Kan
Jan 14, 2021·Future Medicinal Chemistry·Chenxi DuHaopeng Sun
Aug 11, 2019·European Journal of Medicinal Chemistry·Yuting QiaoHaopeng Sun
Dec 29, 2020·Life Science Alliance·Karen DunbarGopal P Sapkota
Dec 3, 2020·International Journal of Molecular Sciences·Pavlína JanovskáVítězslav Bryja
Jan 13, 2021·Nature Communications·Anne-Louise LatifPeter D Adams
Nov 14, 2020·Expert Opinion on Investigational Drugs·Hanzhi LiangHao Fang
Nov 21, 2018·Trends in Pharmacological Sciences·Brian Ball, Omar Abdel-Wahab
May 1, 2021·International Journal of Molecular Sciences·Zaira SpinelloSabrina Manni
Jun 10, 2021·Therapeutic Advances in Musculoskeletal Disease·Hangzhan MaZhenfeng Duan
Jul 25, 2021·Cancers·Elisabetta SautaValentina Sancisi
Jun 27, 2021·The FEBS Journal·Yoshiki Higashijima, Yasuharu Kanki
Oct 15, 2021·European Journal of Immunology·Avner FinkYinon Ben-Neriah
Nov 2, 2021·Frontiers in Oncology·Wenwen ZhangMinyi Zhao
Nov 2, 2021·Frontiers in Oncology·Sabrina ManniFrancesco Piazza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cardiovascular Disease & TET2

Cardiovascular diseases are the number one cause of deaths globally. Tet methylcytosine dioxygenase 2 (TET2)-mediated hematopoiesis has been implicated in accelerating heart failure. Here is the latest research on cardiovascular diseases and TET2.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.